The 2022 American Society of Hematology (ASH) Annual Meeting and Exposition was full of interesting abstracts in multiple myeloma. In addition to full coverage of several important presentations, The ASCO Post offers readers quick takes on some studies that could be practice-changing and others that herald the emergence of yet more novel therapies in this ever-evolving treatment…
In the single-center phase II Natalie trial reported in The Lancet Oncology, investigators assessed the activity of cabozantinib in patients with unresectable and progressive metastatic…
On April 22, the U.S. Food and Drug Administration (FDA) approved nogapendekin alfa inbakicept-pmln (Anktiva) with bacillus Calmette-GuĂ©rin (BCG) for adults with BCG-unresponsive nonâmuscle invasive…
Investigators have examined whether following certain healthy diets may reduce the risk of cardiovascular disease in female breast cancer survivors.
Deeper sedation with the anesthetic drug propofol may improve detection of serrated polyps in patients undergoing colonoscopy to screen for colorectal cancer.
In the single-center phase II Natalie trial reported in The Lancet Oncology, investigators assessed the activity of cabozantinib in patients with unresectable and progressive metastatic…
The phase I/II CheckMate 358 trial assessed nivolumab monotherapy and nivolumab/ipilimumab regimens in patients with recurrent or metastatic cervical squamous cell carcinoma. The study findings…
In a study reported in the Journal of Clinical Oncology, Cao et al found that U.S. adult cancer survivors had higher levels of mobility disability…
A novel single-photon emission computed tomography/computed tomography (SPECT/CT) acquisition method may provide convenient detection of radiopharmaceutical biodistribution and could lead to improved …
A novel MDM2 inhibitor has demonstrated antitumor activity in progressive salivary cancer, particularly adenoid cystic carcinoma, according to data presented at the 2024 Multidisciplinary Head…
Several professional societies have developed evidence-based guidelines on the use of certain biomarkers to help determine which patients with nonâsmall cell lung carcinoma (NSCLC) may…
